Persperity Health, Inc.

Persperity Health, Inc. is a US-based company specializing in non-invasive hormone monitoring solutions for women's health. Their innovative wearable biosensor tracks estradiol levels to enable effective fertility tracking and management of menopause symptoms. Founded in Los Angeles, US, Persperity Health focuses on transforming women's health through continuous hormone monitoring.

The company recently secured USD 1. 000 mn in pre-seed funding in October 2024, led by Freeflow Ventures, with participation from Atma Capital, CalTech, Heritage Group, and Wilson Hill. This funding marks a significant step in their growth strategy, targeting advancements in product development and regulatory approvals. Persperity Health specializes in non-invasive hormone monitoring solutions designed primarily for women's health.

The company's flagship product is a wearable biosensor that continuously tracks estradiol levels through a sweat-based nanobiosensor technology. This device enables real-time hormone monitoring, allowing women to effectively manage fertility, ovulation tracking, and menopause symptoms, such as hot flashes and mood swings. By providing continuous, personalized health insights, the wearable serves a diverse clientele, including women experiencing irregular cycles, those undergoing fertility treatments, and those navigating menopause. Persperity Health's products are primarily marketed in North America and Europe, where there is a growing demand for innovative health technologies that offer precision and convenience without the invasiveness of traditional blood tests.

Persperity Health operates on a direct-to-consumer model, offering its wearable biosensor through subscription plans that provide ongoing access to real-time health insights. Customers can purchase the device along with subscription options that facilitate continuous monitoring and data analysis. Transaction structures are designed to encourage long-term engagement, with pricing reflecting the value of personalized hormone tracking and management. The revenue is generated from the sale of devices and recurring subscription fees for data access and insights.

This business model not only enhances customer retention but also fosters deeper relationships with users by providing actionable health information that evolves over time. In October 2024, Persperity Health, Inc. raised USD 1. 000 mn in pre-seed funding led by new investor Freeflow Ventures, with participation from other new investors CalTech, Wilson Hill Ventures, Heritage Group, and Atma Capital.

The company will use the funding to expedite product development, seek key alliances, and successfully negotiate regulatory approvals. Plans include the introduction of new products designed to enhance the monitoring experience for users and expansion into additional geographic markets.